Vol 14, No 5 (May 30, 2025): Translational Lung Cancer Research

Editorial

Pneumonectomy—a necessary evil?
Koen C. H. A. Verkoulen, Lars Geenen, Aimée J. P. M. Franssen, Lori M. van Roozendaal, Jean H. T. Daemen, Karel W. E. Hulsewé, Yvonne L. J. Vissers, Michel Gonzalez, Francesco Guerrera, Erik R. de Loos

Expert Consensus

Chinese expert consensus on shape-sensing robotic-assisted bronchoscopy (ssRAB) in the management of peripheral pulmonary lesions
Fangfang Xie, Chunxi Zhang, Chun Li, Dan Liu, Quncheng Zhang, Chuanyong Mu, Gang Hou, Manxiang Li, Chunli Tang, Fei Xu, Hong Chen, Zhongbo Chen, Ye Gu, Zhenbiao Guan, Cheng Ji, Haitao Li, Wei Li, Xuan Li, Yishi Li, Hairong Lian, Jiangrong Liao, Zhuang Luo, Haifeng Ouyang, Yongchun Shen, Yiwei Shi, Nansheng Wan, Tao Wang, Hong Wang, Huaqi Wang, Juan Wang, Jingxiang Wu, Xuemei Wu, Yang Xia, Kui Xiao, Wujian Xu, Huizhen Yang, Junyong Yang, Taosheng Ye, Xianwei Ye, Pengfei Yu, Nan Zhang, Peng Zhang, Qi Zhao, Xiaoxuan Zheng, Jun Zou, Enguo Chen, Hao Zhang, Jiayuan Sun; Professional Committee on Interventional Pulmonology of China Association for Promotion of Health Science and Technology; Expert Group on Technology of Shape-sensing Robotic assisted Bronchoscopy

Original Article

A Bayesian deep learning model with consolidation-to-tumor ratio (CTR) prior revolutionizes the prediction of spread through air spaces (STAS) in stage IA lung adenocarcinoma: a large-scale diagnostic study
Jie Cao, Nan Chen, Lingyu Zhou, Le Yi, Zhiyu Peng, Lin Qiu, Haokun Wu, Xiyue Tan, Kunhao Wu, Huahang Lin, Zhaokang Huang, Zetao Liu, Chenglin Guo, Xiuyuan Xu, Zhang Yi, Jiandong Mei
Clinicopathological factors vs. molecular model for predicting adjuvant EGFR-TKI benefit in stage I EGFR-mutant non-small cell lung cancer
Yu Jiang, Yuechun Lin, Wenhai Fu, Si Jiang, Zhexue Hao, Hengrui Liang, Qihua He, Ran Cheng, Bingliang Li, Hongsheng Deng, Caichen Li, Jianfu Li, Shan Xiong, Ran Zhong, Songan Chen, Wei Wang, Jianxing He, Wenhua Liang
Absent preoperative non-small cell lung cancer confirmation and relevant stage migration in the era before neoadjuvant chemoimmunotherapy: implications for treatment decisions in resectable non-small cell lung cancer
Guus R. M. van den Heuvel, Bas L. R. Mandos, Olga C. J. Schuurbiers, Francesco Ciompi, Erik Aarntzen, Kaamar Azijli, Iris Walraven, Hans J. M. Smit, Michel M. van den Heuvel
Outcomes of chemotherapy with or without immunotherapy in older patients with non-small cell lung cancer and low PD-L1 expression
Hayato Kawachi, Tae Hata, Tadaaki Yamada, Yasuhiro Goto, Akihiko Amano, Yoshiki Negi, Satoshi Watanabe, Naoki Furuya, Tomohiro Oba, Tatsuki Ikoma, Akira Nakao, Keiko Tanimura, Hirokazu Taniguchi, Akihiro Yoshimura, Tomoya Fukui, Daiki Murata, Kyoichi Kaira, Shinsuke Shiotsu, Makoto Hibino, Asuka Okada, Yusuke Chihara, Takashi Kijima, Koichi Takayama
Prognostic factors of liver metastases in extensive-stage small cell lung cancer receiving chemo-immunotherapy
Kyoichi Kaira, Yuhei Kurata, Hisao Imai, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Ou Yamaguchi, Atusto Mouri, Hiroshi Kagamu
Change of bone mineral density as a prognostic marker in small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
Weiwei Liu, Yusheng Guo, Peng Mo, Jie Lou, Bingxin Gong, Xiaona Fu, Yi Li, Kailu Zhang, Yi Ren, Shanshan Jiang, Peng Sun, Junping Li, Yong Wang, Lian Yang
Attention mechanism-based habitat analysis for predicting pleural invasion and prognosis of pulmonary nodules
Wei Zhang, Xiangfeng Gan, Wenzeng Chen, Xiaohui Duan, Zhuojian Shen, Haohua Xu, Honglue Dai, Ju Chen, Baishen Chen
Radial endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) enhances diagnostic yield in pulmonary nodule biopsy
Rong Lih Ho, Joong Hyun Ahn, Jung Ho Han, Junsu Choe, Sun Hye Shin, Byeong-Ho Jeong, Sang-Won Eom, Hojoong Kim, Kyungjong Lee
Ivonescimab plus chemotherapy in advanced or metastatic non‐squamous non‐small cell lung cancer with EGFR variant in China: a cost‐effectiveness analysis
Rong Long, Weilu Kuang, Qin Zhou
Pattern-based volumetric CT quantification to predict radiation pneumonitis in patients with non-small-cell lung cancer who have diffuse parenchymal lung disease
Jonghoon Kim, Min Hwan Kwak, Jae Myoung Noh, You Jin Oh, Hongseok Yoo, Hye Jeon Hwang, Joon Beom Seo, Sung Goo Park, Hong Ryull Pyo, Ho Yun Lee
Re-irradiation for local recurrence after definitive stereotactic body radiotherapy for early-stage non-small cell lung cancer
Taiki Takaoka, Natsuo Tomita, Chisa Hashizume, Takahiko Tsugawa, Akira Torii, Dai Okazaki, Masanari Niwa, Nozomi Kita, Masanosuke Oguri, Seiya Takano, Masahiro Sasaguchi, Machiko Ukai, Yasutaka Ogawa, Akio Niimi, Akio Hiwatashi
Impaired natural killer cell maturation in lung adenocarcinoma driven by FABP4 and SPON2 downregulation through disrupted lipid metabolism
Hongxia Tian, Kezhen Li, Jing Chen, Weibang Guo, Zepeng Guo, Shuilian Zhang, Zhi Xie, Xin Huang, Sipei Wu, Wenzhao Zhong
Impact of coronavirus disease 2019 on surgery in patients with early-stage lung cancer: the COVIDLungSurg prospective cohort study
Zhenyi Niu, Feng Zhu, Yuqin Cao, Congcong Luo, Dan Liu, Chunping Wang, Zhenbin Qiu, Lishan Peng, Mingyuan Du, Runsen Jin, Yan Yan, Dong Dong, Hui Jing, Xiaofeng Wang, Wei Guo, Zengya Guo, Chengqiang Li, Dingpei Han, Yajie Zhang, Jie Xiang, Hailei Du, Kai Chen, Zhengxin Yin, Jie Yang, Wenzhao Zhong, Yongxin Zhou, Mingsong Wang, Dongchun Ma, Hecheng Li
Evaluating the tumor response assessment of modified-RECIST 1.1 in advance non-small cell lung cancer: a post-hoc analysis of 1,147 patients from the EAST-LC trial
Qun Chen, Wenwen Huang, Gang Chen, Huaqiang Zhou, Jing Luo, Yuanyuan Zhao, Yan Huang, Yunpeng Yang, Wenfeng Fang, Ting Zhou, Yuxiang Ma, Li Zhang, Hongyun Zhao
Different prognosis of multiple lung cancer identified by 116-gene panel by next-generation sequencing based on an Asian population
Chen-Hui Ni, Mu-Ting Wang, Ping-Hua Lin, Yan-Qi Lu, Yi-Peng Chen, Wei Zheng, Yuan-Zhong Chen, Chang-Ping Yang, Chun Chen, Bin Zheng
Oral microbiome and risk of lung cancer: results from a two-sample mendelian randomization analysis
Chudong Wang, Biao Hu, Qiuyi Liang, Han Jiang, Lu Yuan, Shuben Li
Combination of immune checkpoint inhibitors with multi-targeted tyrosine kinase inhibitors for second- or later-line therapy of non-small cell lung cancer: a systematic review and meta-analysis
Wujian Xu, Ximing Liao, Kun Wang, Ting Shi
Construction of a checkpoint inhibitor-related pneumonia diagnostic model based on exhaled nitric oxide: a prospective observational study
Yimei Gao, Tingyue Luo, Danhui Huang, Zeyu Fu, Shudong Ma, Li Lin, Haohua Huang, Tiantian Liu, Jinming Zhang, Xiaoxiao Jiang, Yanmei Ye, Junwei Chen, Junjie Xi, Jinzhong Zhuo, Kaijun Chen, Jingqi Ai, Laiyu Liu, Shaoxi Cai, Hangming Dong
Deep learning in histopathology images for prediction of oncogenic driver molecular alterations in lung cancer: a systematic review and meta-analysis
Rafael Parra-Medina, Gabriela Guerron-Gomez, Daniel Mendivelso-González, Javier Hernan Gil-Gómez, Juan Pablo Alzate, Marcela Gomez-Suarez, Jose Fernando Polo, John Jaime Sprockel, Andres Mosquera-Zamudio
Impact of omitting clinical target volume in radiotherapy for locally advanced non-small cell lung cancer: a propensity score matching analysis
Liang Liu, Wen Bao, Xiaoshuai Yuan, Yaoyao Zhu, Ying Zhang, Petros Christopoulos, Baptiste Abbar, Cheng Qian, Shuangyan Yang, Yaping Xu
One-year mortality risk prediction model for patients with interstitial lung disease and lung cancer
Xiaorui Ding, Wanqing Zhou, Guanning Zhong, Ranxun Chen, Qingqing Xu, Lulu Chen, Yingwei Zhang, Yi Zhuang, Liyun Miao, Jinghong Dai
Comparative effectiveness of pembrolizumab-chemotherapy versus chemotherapy with/without bevacizumab in unresectable, locally advanced or metastatic non-small cell lung cancer: a Chinese multicenter real-world analysis emphasizing PD-L1-negative populations
Xiaobei Guo, Hui Zhang, Yuequan Shi, Qi He, Anwen Liu, Zhimin Zeng, Jinghui Wang, Song Wei, Tong Zhang, Cuimin Ding, Jian Fang, Xiaoling Chen, Paul Van Schil, Haoran Zhang, Junyi Pang, Minjiang Chen, Jing Zhao, Wei Zhong, Zhen Huo, Yan Xu, Mengzhao Wang

Case Report

Visceral crisis in a patient with non-small cell lung cancer and ROS1::SDC4 fusion: intrinsic resistance to entrectinib via L2026M mutation—a case report
Vaneza Avila Rodriguez, Nicolle Wagner-Gutiérrez, Jairo Andrés Zuluaga León, Leonardo Rojas, Lucia Viola, Stella Isabel Martínez Jaramillo, Carlos Andrés Carvajal Fierro, Alejandro Ruiz-Patiño, Oscar Arrieta, Luis Corrales, Claudio Martin, Andrés F. Cardona
Neoadjuvant tepotinib in stage IIB N0 non-small cell lung carcinoma with MET exon 14 skipping mutation: a case report and review of the literature
Amanda Reyes, Rebecca Pharaon, Atish Mohanty, Jae Kim, Erminia Massarelli